Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 3 de 3
Filtrer
Plus de filtres










Base de données
Gamme d'année
1.
Acta Chir Belg ; 122(2): 127-132, 2022 Apr.
Article de Anglais | MEDLINE | ID: mdl-32375578

RÉSUMÉ

BACKGROUND: Sebaceous carcinoma is an aggressive malignant tumour. To prevent mutilating surgery and improve patient outcomes, early diagnosis and prompt treatment are necessary. When the tumour invades surrounding tissues, treatment may become complex. METHODS: We present a case report illustrating complex resection and reconstruction of a sebaceous carcinoma after initial misdiagnosis. RESULTS: A 74-year-old man with a sebaceous carcinoma to his right upper eyelid had a delay in treatment due to initial misdiagnosis. Upon the correct diagnosis, computed tomography scan showed tumour invasion of the medial rectus muscle and tumour spread to the right parotid gland. An orbital exenteration, partial parotidectomy and selective cervical lymphadenectomy were performed. Frozen section examination showed false-free margins, as additional paraffin embedded sections showed uncomplete tumour resection. Adjuvant radiotherapy was offered to the patient. The treatment was complicated by radio necrosis, necessitating surgical reconstruction by a paramedian forehead flap. Final reconstruction of the right orbit was accomplished by a personalised epithesis. CONCLUSIONS: Sebaceous carcinoma is a tumour that is often misdiagnosed. The aim of this case report is to emphasize the possible consequences of its misdiagnosis. An overview of characteristic clinical findings is provided to help reduce the number of misdiagnoses.


Sujet(s)
Adénocarcinome sébacé , Tumeurs de la paupière , Tumeurs des glandes sébacées , Adénocarcinome sébacé/diagnostic , Adénocarcinome sébacé/anatomopathologie , Adénocarcinome sébacé/chirurgie , Sujet âgé , Erreurs de diagnostic , Tumeurs de la paupière/diagnostic , Tumeurs de la paupière/anatomopathologie , Tumeurs de la paupière/chirurgie , Humains , Mâle , Tumeurs des glandes sébacées/diagnostic , Tumeurs des glandes sébacées/anatomopathologie , Tumeurs des glandes sébacées/chirurgie , Tomodensitométrie
2.
Article de Anglais | MEDLINE | ID: mdl-32002459

RÉSUMÉ

We present a 30-year-old man with a sternal Ewing's sarcoma, who was treated by complex resection of the sternal body and reconstruction by a methyl methacrylate sandwich graft and a pedicled latissimus dorsi flap.

3.
Crit Rev Oncol Hematol ; 120: 141-150, 2017 Dec.
Article de Anglais | MEDLINE | ID: mdl-29198328

RÉSUMÉ

Background The Nuclear Factor kappaB (NF-kB) family consists of transcription factors that play a complex and essential role in the regulation of immune responses and inflammation. NF-kB has recently generated considerable interest as it has been implicated in human cancer initiation, progression and resistance to treatment. In the present comprehensive review the different aspects of NF-kB signaling in the carcinogenesis of cancer of the uterine cervix are discussed. NF-kB functions as part of a network, which determines the pattern of its effects on the expression of several other genes (such as crosstalks with reactive oxygen species, p53, STAT3 and miRNAS) and thus its function. Activation of NF-kB triggered by a HPV infection is playing an important role in the innate and adaptive immune response of the host. The virus induces down regulation of NF-kB to liquidate the inhibitory activity for its replication triggered by the immune system leading a status of persistant HPV infection. During the progression to high grade intraepithelial neoplasia and cervical cancer NF-KB becomes constitutionally activated again. Mutations in NF-kB genes are rare in solid tumors but mutations of upstream signaling molecules such as RAS, EGFR, PGF, HER2 have been implicated in elevated NF-kB signaling. NF-kB can stimulate transcription of proliferation regulating genes (eg. cyclin D1 and c-myc), genes involved in metastasis, VEGF dependent angiogenesis and cell immortality by telomerase. NF-kB activation can also induce the expression of activation-induced cytodine deaminase (AID) and the APOBEC proteins, providing a mechanistic link between the NF-kB pathway and mutagenic characteristic of cervical cancer. Inhibition of NF-kB has the potential to be used to reverse resistance to radiotherapy and systemic anti-cancer medication, but currently no clinicaly active NF-kB targeting strategies are available.


Sujet(s)
Facteur de transcription NF-kappa B/métabolisme , Tumeurs du col de l'utérus/métabolisme , Femelle , Humains , Transduction du signal , Tumeurs du col de l'utérus/anatomopathologie
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE